Roberts v. the Future: Genetic Screening and the Future of Personal Autonomy
By New York Times,
New York Times
| 08. 28. 2005
III. Genetic Screening and the Future of Personal Autonomy
Every Supreme Court confirmation hearing since the election of Ronald Reagan has been marked by efforts -- nearly always unsuccessful -- to predict the nominee's views on Roe v. Wade. The Roberts hearings are unlikely to prove an exception. If Roberts is confirmed, he will have two opportunities in the next Supreme Court term to reveal some of his views about the potential implications of Roe -- in one case involving a teen-health exception in parental-notification laws and in another concerning the federal power to prosecute protesters at abortion clinics. Regardless of whether Roe v. Wade remains on the books in 10 or 20 years, however, America's political and legal disputes about reproduction may well have moved far beyond efforts to balance the interests of a fetus against the interests of a pregnant mother. Instead, the country will most likely be debating the use of sophisticated technologies involving genetic manipulation and reproductive cloning outside the womb -- controversial procedures that may prompt restrictions or bans by state legislatures or Congress. In...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...